Nazara Approves Leadership Transition, Preferential Allotment, and Subsidiary Capital Infusions
Nazara Technologies Ltd · Change in Management · 12 Oct 2026, 11:58 pm
Nazara Approves Leadership Transition, Preferential Allotment, and Subsidiary Capital Infusions On 12th Oct'26, Nazara Technologies approved key leadership changes: Founder Nitish Mittersain transitioned from MD to Non-Executive Director, Mithun Sacheti was appointed Executive Director, and Arun Agrawal became CFO effective 16th Oct'26, succeeding Rakesh Shah. The board allotted 2.39 crore equity shares at ₹306 each (~₹730.78 crore) on a preferential basis. Additionally, it approved infusing up to $77 million (~₹742.72 crore) into Nazara UK and converting inter-corporate loans of ~₹129.35 crore in Smaaash and ~₹294.40 crore in Nazara UK into equity.
Original exchange filing (PDF)
More announcements from Nazara Technologies Ltd
- Nazara Technologies Limited informs the Exchange about Schedule of meet. · 17 Nov 2026
- Monitoring Agency Report for the quarter ended September 30, 2026. · 14 Nov 2026
- Nazara Technologies Limited informs the Exchange about Schedule of meet(s). · 13 Nov 2026
- Nazara Technologies Limited informs the Exchange regarding Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Update. · 31 Oct 2026
- Nazara Technologies Limited informs the Exchange about Transcript. · 30 Oct 2026
- Nazara Technologies Limited informs the Exchange about Link of Recording. · 27 Oct 2026
- Monitoring Agency Report for the quarter ended September 30, 2026. · 27 Oct 2026
- Nazara Technologies Limited informs the Exchange regarding Investor Presentation. · 27 Oct 2026
